(Total Views: 525)
Posted On: 06/22/2020 11:32:54 PM
Post# of 149009
Sorry, had a meaningful typo in the last version of this post and was outside my "Edit Msg" window:
1. Do we know that Dr.BP started measuring viral load with the first patient in both trials? I know that the pre-print of his manuscript contained Plasma Viral Load graphs. Just not sure every trial subject was tested and documented that way.
2. Is the FDA possibly so stringent in their submission regulations that there is not facility for providing additional data points (viral load) beyond what is officially included in the trial protocol?
Read More: https://investorshangout.com/post/view?id=580...z6Q9jIgDZ4
1. Do we know that Dr.BP started measuring viral load with the first patient in both trials? I know that the pre-print of his manuscript contained Plasma Viral Load graphs. Just not sure every trial subject was tested and documented that way.
2. Is the FDA possibly so stringent in their submission regulations that there is not facility for providing additional data points (viral load) beyond what is officially included in the trial protocol?
Read More: https://investorshangout.com/post/view?id=580...z6Q9jIgDZ4
(0)
(0)Scroll down for more posts ▼
